Taletrectinib
(ta-le-TREK-tin-ib)
This page contains brief information about taletrectinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
Ibtrozi
FDA Approved
Yes
FDA label information for this drug is available at DailyMed.
Use in Cancer
Taletrectinib is approved to treat adults whose cancer is HER2 positive, including:
- non-small cell lung cancer that has spread and has certain changes in the ROS1 gene.
More About Taletrectinib
Definition from the NCI Thesaurus - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Taletrectinib - A lay language summary of important information about this drug.
Research Results and Related Resources
Targeted Therapy to Treat Cancer
Clinical Trials Accepting Patients
Find Clinical Trials for Taletrectinib - Check for trials from NCI's list of cancer clinical trials now accepting patients.